Recombinant adeno-associated virus vector expressing angiostatin inhibits preretinal neovascularization in adult rats

Ophthalmic Research

Volumn 37, Issue 1, 2005, Pages 50-56

  Lai, Chi Chun ^a   Wu, Wei Chi ^a   Chen, Show Li ^b   Sun, Ming Hui ^a   Xiao, Xiao ^d   Ma, Lih ^a   Lin, Keng Kuo ^a   Tsao, Yeou Ping ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Angiostatin; Gene therapy; Preretinal neovascularization; Recombinant adeno associated virus vector

Indexed keywords

ANGIOSTATIN; BETA GALACTOSIDASE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; PARVOVIRUS VECTOR; RECOMBINANT ANGIOSTATIN; RECOMBINANT PROTEIN; ROSE BENGAL; UNCLASSIFIED DRUG;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; CONTROLLED STUDY; ELECTRORETINOGRAM; ELECTRORETINOGRAPHY; EXPERIMENTAL MODEL; EYE; GENE EXPRESSION; GENETIC ANALYSIS; INHIBITION KINETICS; INJECTION; LASER; NONHUMAN; PRIORITY JOURNAL; RAT; RECORDING; RETINA; RETINA DISEASE; RETINA NEOVASCULARIZATION; RETINA VEIN OCCLUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICITY; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ANGIOSTATINS; ANIMALS; DEFECTIVE VIRUSES; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; FLUORESCEIN ANGIOGRAPHY; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; RATS; RATS, SPRAGUE-DAWLEY; RETINAL NEOVASCULARIZATION; RETINAL VEIN OCCLUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSGENES;

EID: 18644369180     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083040     Document Type: Article

References (34)

1. Hayreh SS, Rojas P, Podhajsky P, et al: Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983;90:488-506.
2. Aiello LP, et al: Diabetic retinopathy. Diabetes Care 1998;21:143-156.
3. Jampol LM, Ebroon DA, Goldbaum MH: Peripheral proliferative retinopathy: An update on angiogenesis, etiologies and management. Surv Ophthalmol 1994;38:518-540.
4. Magargal LE, Donoso LA, Sanborn GE: Retinal ischemia and risk of neovascularization following central retinal vessel occlusion. Ophthalmology 1982;89:1241-1245.
5. Dwyer MS, Melton LJ 3rd, Ballard DJ, et al: Incidence of diabetic retinopathy and blindness: A population-based study in Rochester, Minnesota. Diabetes Care 1985;8:316-322.
6. Evans K, Wishart PK, McGalliard JN: Neovascular complications after central retinal vein occlusion. Eye 1993;7:520-524.
7. Magargal LE, Brown GC, Augsburger JJ, et al: Neovascular glaucoma following central retinal vein obstruction. Ophthalmology 1981;88:1095-1101.
8. Hayreh SS, Klugman MR, Podhajsky P, et al: Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion: A 10-year prospective study. Graefes Arch Clin Exp Ophthalmol 1990;228:281-296.
9. The Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study. DRS report No 8. Ophthalmology 1981;88:583-600.
10. Benedett R, Olk RJ, Arribas NP, et al: Transconjunctival anterior retinal cryotherapy for proliferative diabetic retinopathy. Ophthalmology 1987;94:612-619.
11. Fekrat S, Finkelstein D: Current concepts in the management of central retinal vessel occlusion. Curr Opin Ophthalmol 1997;8:50-54.
12. Blankenship GW: Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: A laboratory and clinical comparison. Trans Am Ophthalmol Soc 1986;84:967-1003.
13. O'Reilly MS, Holmgren L, Shing Y, et al: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328.
14. Meneses PI, Hajjar KA, Duvoisin RM: Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinopathy model. Gene Ther 2001;8:646-648.
15. Drixler TA, Rinkes IH, Ritchie ED, et al: Angiostatin inhibits pathological but not physiological retinal angiogenesis. Invest Ophthalmol Vis Sci 2001;42:3325-3330.
16. Flannery JG, Zolotuklin S, Vaquero MI, et al: Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA 1997;94:6916-6921.
17. Mori K, Gehlbach P, Yamamoto S, et al: AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 2002;43:1994-2000.
18. Pan RY, Chen SL, Xiao X, et al: Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist. Arthritis Rheum 2000;43:289-297.
19. Pruchnic R, Cao B, Peterson ZQ, et al: The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers. Hum Gene Ther 2000;11:521-536.
20. Raisler BJ, Berns KI, Grant MB, et al: Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or kringles 1-3 of angiostatin reduce retinal neovascularization. Proc Natl Acad Sci USA 2002;99:8909-8914.
21. Lai CC, Wu WC, Chen SL, et al: Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin. Invest Ophthalmol Vis Sci 2001;42:2401-2407.
22. Xiao X, Li J, McCown J, Samulski RJ: Gene transfer by adeno-associated virus vectors into the central nervous system. Exp Neurol 1997;144:113-124.
23. Saito Y, Park L, Skolik SA, et al: Experimental preretinal neovascularization in rats. Curr Eye Res 1997;16:26-33.
24. Kang SG, Chung H, Hyon JY: Experimental preretinal neovascularization by laser-induced thrombosis in albino rats. Korean J Ophthalmol 1999;35:65-70.
25. D'Amoto R, Wesolowski E, Smith LE: Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. Microvasc Res 1993;46:135-142.
26. Igarashi T, Miyake K, Kato K, et al: Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model. Gene Ther 2003;10:219-226.
27. Hamanaka T, Akabane N, Yajima T, et al: Retinal ischemia and angle neovascularization in proliferative diabetic retinopathy. Am J Ophthalmol 2001;132:648-658.
28. Smith LE, Shen W, Perruzzi C, et al: Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 1999;5:1390-1395.
29. Auricchio A, Behling KC, Maguire AM, et al: Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents. Mol Ther 2002;6:490-494.
30. Luo J, Lin J, Paranya G, Bischoff J: Angiostatin upregulates E-selectin in proliferating endothelial cells. Biochem Biophys Res Commun 1998;245:906-911.
31. Lucas R, Holmgren L, Garcia I, et al: Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 1998;92:4730-4741.
32. Stack MS, Gately S, Bafetti LM, et al: Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. Biochem J 1999;340:77-84.
33. Moster TL, Stack MS, Asplin I, et al: Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 1999;96:2811-2816.
34. Liu J, Razani B, Tang S, Terman BI, et al: Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells: Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. J Biol Chem 1999;272:15781-15785.